First witness testifies in NYC trial over a small AI company's claim that Johnson & Johnson stole its surgical robotics tech.

In the latest trading session, Johnson & Johnson (JNJ) closed at $162.84, marking a +0.02% move from the previous day. This change lagged the S&P 500's 0.64% gain on the day. Elsewhere, the Dow saw an ...

We recently published a list of 14 Best Holding Company Stocks to Buy Right Now. In this article, we are going to take a look ...

Following former J&J MedTech Neurovascular Worldwide President Mark Dickinson’s announcement last week that he was leaving ...

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Michael Bodner announced on LinkedIn that he's taking on a new position at Johnson & Johnson MedTech (NYSE:JNJ).

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

the company accelerates innovation across joint reconstruction, trauma, spine, and more Expanding on last year's innovations, Johnson & Johnson MedTech is introducing cutting-edge implants ...